Evidence map›Paper›PMID 35822419›Full record

ArticleThe British journal of dermatology2022

Time to next treatment and safety assessment in cutaneous-T-cell lymphomas: a retrospective analysis on patients treated with bexarotene and acitretin.

Gabriele Roccuzzo, Paolo Fava, Gianluca Avallone, Carola Aquino, Sara Boskovic, Nicole Macagno, Simone Ribero, Pietro Quaglino

Abstract readLetter
In one paragraph

Article in The British journal of dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Observational
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gabriele RoccuzzoSection of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy.ORCID 0000-0001-7126-5506
Paolo FavaSection of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy.ORCID 0000-0002-8443-7458
Gianluca AvalloneSection of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy.ORCID 0000-0001-7253-2370
Carola AquinoSection of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy.
Sara BoskovicSection of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy.
Nicole MacagnoSection of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy.
Simone RiberoSection of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy.ORCID 0000-0002-0098-1406
Pietro QuaglinoSection of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy.ORCID 0000-0003-4185-9586

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anticarcinogenic AgentsLymphoma, T-Cell, CutaneousSkin NeoplasmsAcitretinBexaroteneHumansRetrospective StudiesTetrahydronaphthalenesAcitretinAnticarcinogenic AgentsBexaroteneTetrahydronaphthalenes

Identifiers

PMID35822419
PMCPMC10087863

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.